                         SEQUENCE LISTING

<110>  UNIVERSITY COLLEGE DUBLIN
       UNIVERSITY OF LIMERICK
 
<120>  Peptides and compositions thereof for improvement of glycaemic 
       management in a mammal

<130>  P11270PC00

<150>  14167891.2
<151>  2015-05-12

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

His Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe Pro Pro Gln 
1               5                   10                  15      


Ser Val Leu 
            


<210>  2
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

His Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe Pro Pro Gln 
1               5                   10                  15      


Ser Val Leu Ser Leu Ser Gln Ser Lys 
            20                  25  


<210>  3
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Leu Gln Ser Trp Met His Gln Pro His Gln Pro Leu Pro Pro Thr Val 
1               5                   10                  15      


Met Phe Pro Pro Gln Ser Val Leu 
            20                  


<210>  4
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Leu Gln Ser Trp Met His Gln Pro His Gln Pro Leu Pro Pro Thr Val 
1               5                   10                  15      


Met Phe Pro Pro Gln Ser Val Leu Ser Leu Ser Gln Ser Lys 
            20                  25                  30  


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Pro Pro Gln Ser Val Leu Ser Leu Ser Gln Ser Lys 
1               5                   10          


<210>  6
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  6

Met His Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe Pro Pro 
1               5                   10                  15      


Gln Ser Val Leu 
            20  


<210>  7
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  7

Met His Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe Pro Pro 
1               5                   10                  15      


Gln Ser Val Leu Ser Leu Ser Gln Ser Lys 
            20                  25      


<210>  8
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence

<400>  8

Ser Trp Met His Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe 
1               5                   10                  15      


Pro Pro Gln Ser Val Leu 
            20          


<210>  9
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Ser Trp Met His Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe 
1               5                   10                  15      


Pro Pro Gln Ser Val Leu Ser Leu Ser Gln Ser Lys 
            20                  25              


<210>  10
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Tyr Pro Val Glu Pro Phe Thr Glu Ser Gln Ser Leu Thr Leu Thr Asp 
1               5                   10                  15      


Val Glu Asn Leu His Leu Pro Leu Pro Leu Leu Gln Ser Trp Met His 
            20                  25                  30          


Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe Pro Pro Gln Ser 
        35                  40                  45              


Val Leu 
    50  


<210>  11
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Tyr Pro Val Glu Pro Phe Thr Glu Ser Gln Ser Leu Thr Leu Thr Asp 
1               5                   10                  15      


Val Glu Asn Leu His Leu Pro Leu Pro Leu Leu Gln Ser Trp Met His 
            20                  25                  30          


Gln Pro His Gln Pro Leu Pro Pro Thr Val Met Phe Pro Pro Gln Ser 
        35                  40                  45              


Val Leu Ser Leu Ser Gln Ser Lys 
    50                  55      


